ICM
MET icon

Invenomic Capital Management’s MetLife MET Stock Holding History

Invenomic Capital Management’s Portfolio MET Stock Details MET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-22,215
Closed -$1.37M – 158
2021
Q3 		$1.37M Buy
22,215
+8,476
+62% +$510K 0.45% 72
2021
Q2 		$822K Sell
13,739
-17,685
-56% -$1.12M 0.2% 88
2021
Q1 		$1.91M Buy
+31,424
New +$1.73M 0.43% 46

Other funds holding MET

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Invenomic Capital Management's MET Position: Q4 2021 in Review

Invenomic Capital Management sold out of MetLife (MET) in Q4 2021, closing a stake of 22,215 shares — an estimated $1.37M sold.

Invenomic Capital Management first reported a position in MET in Q1 2021 and held it in 3 quarters. The position peaked at $1.91M in Q1 2021. 1,193 funds tracked by Wall St. Rank hold MET as of Q4 2021.

  • Invenomic Capital Management reported no remaining MetLife position as of Q4 2021 after selling out during the quarter.
  • Invenomic Capital Management sold 22,215 MetLife shares in Q4 2021, an estimated $1.37M.
  • Invenomic Capital Management first reported a position in MetLife in Q1 2021 and held it in 3 quarters.
  • Invenomic Capital Management's MetLife position peaked at $1.91M in Q1 2021.
  • 1,193 funds tracked by Wall St. Rank held MetLife as of Q4 2021.

Based on Invenomic Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.